Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Apoorva Ratnakar Barve"'
Autor:
Apoorva Ratnakar Barve, Gauri Ramchandra Kapileshwari, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Anand Avinash Mahajan, Asmita Sunil Arondekar, Rupesh Kalidas Shirodkar
Publikováno v:
Assay and drug development technologies. 20(6)
Ebastine, a histamine H1 antagonist, nonsedating, belonging to BCS class II is used in the treatment of allergic rhinitis and chronic idiopathic urticaria. The current study was intended in augmenting the aqueous solubility and dissolution rate of eb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a539ab6e40b443216ca31507d30580
https://pubmed.ncbi.nlm.nih.gov/36070596
https://pubmed.ncbi.nlm.nih.gov/36070596
Autor:
Lalit Kumar, Apoorva Ratnakar Barve, Gauri Ramchandra Kapileshwari, Rupesh K. Shirodkar, Madhusudan Purushottam Joshi, Prashant Jivaji Bhide
Publikováno v:
Journal of Drug Delivery Science and Technology. 55:101302
Dermatophytes, a group of fungal species causing superficial fungal infections possess a major health problem in a wide group of people. Various approaches have been used in past for treatment of such infections but, owning to their low dermal permea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51dabcb4b723913d5a60b239dd1cc1c1
https://doi.org/10.1016/j.jddst.2019.101302
https://doi.org/10.1016/j.jddst.2019.101302
Autor:
Barve, Apoorva Ratnakar, Kapileshwari, Gauri Ramchandra, DCruz, Cleona Elizabeth Mary, Kumar, Lalit, Bhide, Prashant Jivaji, Mahajan, Anand Avinash, Arondekar, Asmita Sunil, Shirodkar, Rupesh Kalidas
Publikováno v:
Assay & Drug Development Technologies; Aug/Sep2022, Vol. 20 Issue 6, p258-273, 16p